Aetiology of migraine and prevention with carbamazepine (Tegretol) : results of a double-blind, cross-over study
Rompel, H.; Bauermeister, P.W.
South African Medical Journal 44(4): 75-80
1970
ISSN/ISBN: 0256-9574 PMID: 4905910 Document Number: 25424
Document emailed within 1 workday
Related Documents
Wörz, R.; Reinhardt-Benmalek, B.; Föh, M.; Grotemeyer, K.H.; Scharafinski, H.W. 1992: Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol Fortschritte der Medizin 110(14): 268-272Frenken, C.W.; Nuijten, S.T. 1984: Flunarizine--a new agent for migraine prevention. Results of a double-blind comparison with placebo Fortschritte der Medizin 102(12): 349-351
Russell, M.B.; Holm-Thomsen, O.E.; Nielsen, M.R.; Cleal, A.; Pilgrim, A.J.; Olesen, J. 1995: Sumatriptan treatment of migraine in general practice. a randomized, double-blind, placebo-controlled cross-over study Ugeskrift for Laeger 157(16): 2320-2323
Langohr, H.D.; Reinecke, M.; Gerber, W.D.; Mangold, R. 1988: Dihydroergotamine and flunarizine in the prevention of migraine. A comparative double-blind study Fortschritte der Medizin 106(2): 65
Pothmann, R. 1987: Prevention of migraine with flunarizine and acetylsalicylic acid. A double-blind study Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 135(9): 646-649
Grotemeyer, K.H.; Schlake, H.P.; Husstedt, I.W. 1988: Prevention of migraine with metoprolol and flunarizine. A double-blind crossover study Der Nervenarzt 59(9): 549-552
Lynggaard, F.; Ostergaard, F. 1975: Clonidine in prevention of migraine. Report of a double-blind study of 38 patients referred for neurological assessment Ugeskrift for Laeger 137(3): 149-151
Paterna, S.; Martino, S.G.; Campisi, D.; Cascio Ingurgio, N.; Marsala, B.A. 1990: Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study La Clinica Terapeutica 134(2): 119-125
Lerer, B.; Moore, N.; Meyendorff, E.; Cho, S.R.; Gershon, S. 1987: Carbamazepine versus lithium in mania: a double-blind study Journal of Clinical Psychiatry 48(3): 89-93
Vo, A.H.; Satori, R.; Jabbari, B.; Green, J.; Killgore, W.D.S.; Labutta, R.; Campbell, W.W. 2007: Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial Aviation Space and Environmental Medicine 78(5 Suppl): B113-B118
Leeton, J.; McMaster, R.; Worsley, A. 1978: The effects on sexual response and mood after sterilization of women taking long-term oral contraception: results of a double-blind cross-over study Australian and New Zealand Journal of Obstetrics and Gynaecology 18(3): 194-197
Baust, W.; Stürtzbecher, K.H. 1978: Management of migraine using acupuncture in a double-blind study Die Medizinische Welt 29(16): 669-673
Sobaniec, W.; Kułak, W.; Smigielska-Kuzia, J.; Boćkowski, L.; Majkowski, J.; Jedrzejczak, J. 2004: A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients Polish Journal of Pharmacology 56(2): 195-201
Di Trapani, G.; Mei, D.; Marra, C.; Mazza, S.; Capuano, A. 2000: Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study La Clinica Terapeutica 151(3): 145-148
Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Ericson, S. 1977: Phenoxymethylpenicillin preparations. a double-blind cross over study Ugeskrift for Laeger 139(46): 2740-2742
Sulman, F.G.; Pfeifer, Y.; Superstine, E. 1981: Preventive treatment of serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94). A double-blind study Arzneimittel-Forschung 31(1): 109-112
Van der Rijt, C.C.; Schalm, S.W.; Meulstee, J.; Stijnen, T. 1995: Flumazenil therapy for hepatic encephalopathy. a double-blind cross over study Gastroenterologie Clinique et Biologique 19(6-7): 572-580
Salonen, R.; Ashford, E.A.; Gibbs, M.; Hassani, H. 1999: Patient preference for oral sumatriptan 25 mg, 50 mg, or 100 mg in the acute treatment of migraine: a double-blind, randomized, crossover study. Sumatriptan Tablets S2CM11 Study Group International Journal of Clinical Practice. Supplement 105: 16-24
Coccia, G.; Michetti, P.; Rossetti, S.; Dodero, M. 1985: Double-blind cross-over study of imecromone and placebo in the treatment of dyspeptic syndrome Minerva Dietologica E Gastroenterologica 31(2): 293-298